Previous studies have demonstrated that a human glutathione conjugate transporter, designated as dinitrophenyl-S-glutathione ATPase (DNP-SG ATPase), catalyzed ATP hydrolysis in the presence of several amphiphilic compounds other than glutathione conjugates (Singhal, S. S., R. Sharma, S. Gupta, H. Ahmad, P. Zimniak, A. Radominska, R. Lester, and Y. C. Awasthi. 1991. FEBSIFed. ). We now demonstrate that DNP-SG ATPase purified from human lung and erythrocyte membranes catalyzed the hydrolysis of ATP in the presence of doxorubicin and its metabolites. Doxorubicin-stimulated ATP hydrolysis by DNP-SG ATPase was saturable with respect to doxorubicin (Km 1.2 and 2.8 MM for the lung and erythrocyte enzymes, respectively). Antibodies against DNP-SG ATPase immunoprecipitated the ATP hydrolyzing activity stimulated by doxorubicin, its metabolites, and glutathione conjugates. Inside out vesicles prepared from erythrocyte membranes took up doxorubicin, daunomycin, and vinblastine in an ATP-dependent manner. The uptake was linear with respect to time and vesicle protein, was dependent on ATP and magnesium, was inhibited by heavy metal salts or by heating the vesicles, and was sensitive to both osmolarity and orientation of the vesicles. The transport had an activation energy of 13 kcal/mol, was saturable with respect to both doxorubicin and ATP (K. values of 1.8 ,M and 1.9 mM, respectively), and was competitively inhibited by glutathione conjugates as well as by a number ofamphiphiles such as daunomycin or vinblastine. Transport was diminished upon coating the vesicles with antibodies against DNP-SG ATPase. Incorporation of increasing amounts of purified DNP-SG ATPase into the vesicles resulted in a linear increase in transport of doxorubicin. These studies demonstrated for the first time that a membrane protein that catalyzed the transport of anionic amphiphilic molecules such as glutathione conjugates could also mediate the transport of weakly cationic antitumor antibiotic, doxorubicin. Notably, the Km of transport was in the range of doxorubi-
Introduction
Doxorubicin hydrochloride (DOX', Adriamycin®; Farmitalia, Milan, Italy) is an effective cytoreductive agent for chemotherapy of a variety of neoplasms, but its efficacy is limited by inherent or acquired resistance to its cytocidal effects in cancer cells ( 1) . Studies of DOX resistance have shown that cultured malignant cells resistant to DOX frequently exhibit a multidrug resistant (MDR) phenotype associated with the ATP-dependent efflux of a number of amphiphilic cytotoxins such as DOX, vincristine, and vinblastine (2) (3) (4) (5) (6) (7) . A number of these malignant cell lines with the MDR phenotype overexpress the P-glycoprotein, a 170-kD glycoprotein product of the mdr-1 gene (5, 8) . The P-glycoprotein has been demonstrated to mediate the ATP-dependent efflux ofDOX and other amphiphilic drugs (3) (4) (5) (6) (7) (8) . Several studies have also documented the existence of an MDR phenotype in malignant cell lines which do not overexpress the P-glycoprotein (9-13). Increased efflux of DOX from MDR cells which do not overexpress P-glycoprotein has also been demonstrated (5, (11) (12) (13) , suggesting that efflux mechanism(s) distinct from P-glycoprotein may be involved in the exclusion of DOX or similar amphiphilic compounds.
ATP-dependent transport of oxidized glutathione and conjugates of GSH and xenobiotics across human erythrocyte membrane is known (14) (15) (16) , and ATPases catalyzing hydrolysis of ATP in the presence of conjugates of xenobiotics and GSH ( 17) and oxidized glutathione ( 18) have been identified in human erythrocyte membrane. A transporter of glutathione-xenobiotic (GS-X) conjugates (16, 17) present in the membrane of human erythrocytes and other cells (19) catalyzed ATP hydrolysis in presence of not only GS-X conjugates but also in the presence ofseveral structurally unrelated amphiphilic compounds including estradiol glucuronide, bilirubin ditaurate, lithocholic acid 3-O-glucuronide, and leukotriene C4 methyl ester (20, 21 ). We hypothesize that this GS-X conju-gate transporter, previously designated as DNP-SG ATPase because of its routinely used model substrate dinitrophenyl-Sglutathione (DNP-SG) (16, 17) , may be involved in the energy-dependent efflux of other structurally unrelated amphiphilic compounds such as DOX and may thus be a contributory factor in the mechanism(s) for DOX resistance in malignant cells not overexpressing the P-glycoprotein. This report demonstrates that DNP-SG ATPase purified from human erythrocytes and lung tissue stimulated ATP hydrolysis in the presence of DOX and its metabolites. Furthermore, we have demonstrated that DOX, daunomycin, and vinblastine were taken up by inside out vesicles (IOVs) prepared from membranes of human erythrocytes (which do not express the P-glycoprotein) through an ATP-dependent process. The uptake of DOX was competitively inhibited by substrates of the GS-X pump (DNP-SG ATPase) as well as by prototypical substrates of the P-glycoprotein transporter. The transport of DOX was also inhibited by polyclonal antibodies specific to DNP-SG ATPase. Incorporation ofpurified DNP-SG ATPase into erythrocyte IOVs more than doubled the rate of DOX transport. These studies suggest a close similarity between the transport mechanisms of DOX and GS-X conjugates. Possible implications of these findings in the mechanisms of drug resistance and strategies of cancer chemotherapy are discussed in this report.
Methods
Materials. Use of human tissues was approved by the Institutional Review Board. Blood collected from normal subjects and stored for < 1 wk was obtained from the Blood Bank, and human lung samples from adult subjects without known pulmonary disorders deceased < 8 h were collected from the autopsy service. Sources of reagents used in the present studies were the same as described previously (21) . DOX (AdriamycinO), doxorubicinone, dihydrodoxorubicinone, deoxydoxorubicinone, dihydrodoxorubicin, and vinblastine sulfate were generously provided by Dr MO) . Taurodeoxycholate and taurolithocholate (sodium salts) were purchased from Calbiochem-Novabiochem Corp. (La Jolla, CA). The conjugate of l-chloro-2,4-dinitrobenzene and GSH, 2,4-dinitrophenyl-S-glutathione (DNP-SG), was synthesized enzymatically, purified, and authenticated according to our previously published method (22) and was linked to CNBr-activated Sepharose 4B according to a method described previously (21 ) . GSH conjugate ofethacrynic acid (EA-SG) was synthesized and authenticated as described by us previously (23) . Polyclonal antibodies against human erythrocyte DNP-SG ATPase and glyceraldehyde 3-phosphate dehydrogenase, raised in rabbits, were the same as those used in previous studies ( 19) . The IgG fractions were isolated from these antibodies and the preimmune serum by DEAEcellulose ion-exchange chromatography and were purified further using a column of protein A bound to CNBr-activated Sepharose 6MB.
Enzyme assays andpurification ofDNP-SGA TPase. ATPase activity in the presence of DNP-SG, DOX, and other substrates was determined according to the method used by us previously (21 ) . 1 mU of enzyme activity was defined as 1 nmol ATP hydrolysis/min at 37°C. Purifications of DNP-SG ATPase from human lung were performed at 4VC according to a previously described protocol (21) . The details of purification of DNP-SG ATPase from human erythrocytes have also been reported in our previous studies ( 19) . Because of interference by lubrol PX (Sigma Chemical Co.) used during purification, protein was estimated by the method of Minamide and Bamburg (24) . SDS-PAGE, Western blot analysis, and immunotitration of DNP-SG ATPase were performed by methods used by us previously ( 19, 21 (25) in which human erythrocyte ghosts prepared according to the method of Dodge et al. (26) were diluted in 40 vol of 0.5 mM sodium phosphate buffer, pH 8.0, and were allowed to incubate overnight at 4VC. The pellet obtained by centrifugation at 28,000 g for 1 h was resuspended in the same buffer, and vesiculation was performed by repeatedly passing the suspension through a 27-gauge needle. Vesiculation performed in presence or absence of 250 mM sucrose resulted in vesicles with similar yield and transport properties. The IOVs were purified either by density gradient centrifugation at 105,000 g for 2 h over a dextran barrier ( 1.03 g/ml) during which the ROVs and unsealed ghosts pelleted to the bottom, or by passing the mixture of vesicles over a column ( 1 cm X 5 cm) of wheat germ agglutinin bound to CNBr-activated Sepharose 4B. In the latter procedure, the ROVs were almost quantitatively retained by the column, whereas the IOVs were recovered in the flow-through fraction of the column. The ROVs were eluted from the column with 50 mM methyl-a-D-mannopyranoside. The purities of the IOVs and ROVs were estimated by comparing acetylcholinesterase activities in the erythrocyte ghosts and the vesicles using the assay described by Ellman et al. (27) . Both IOVs and ROVs were finally suspended in buffer containing 250 mM sucrose in 10 mM Tris-HCl, pH 7.4 .
Transport studies with DOX and other P-glycoprotein substrates.
For the transport studies, stock solutions of 10 mM MgCl2 and 20 mM 
Results
The results of purification of DNP-SG ATPase from human lung, presented in ( 19, 21 ). In Western blots ( Fig. 1 B) , the enzyme was recognized by polyclonal antibodies raised in rabbits against human erythrocyte DNP-SG ATPase.
The specific activity of the purified enzyme from lung towards DNP-SG was comparable with that reported for the erythrocyte and muscle enzymes ( 19, 21) . In parallel experiments, human erythrocyte DNP-SG ATPase was also purified. ATP hydrolysis catalyzed by the lung and erythrocyte enzymes in the presence of various S-alkyl-and S-aryl-glutathione conjugates (Table II) was similar to that previously reported for human muscle DNP-SG ATPase (21 ) . In general, the long alkyl chain conjugates exhibited higher activity than the conjugates with shorter alkyl chain. These results indicated that the lung enzyme was similar and probably identical to the DNP-SG ATPase characterized previously from human erythrocytes and muscle (19, 21) .
Catalysis ofA TP hydrolysis in the presence ofDOX. Purified human lung DNP-SG ATPase not only catalyzed the hydrolysis of ATP in the presence of DOX and its metabolites, but comparatively higher ATPase activity of the enzyme was observed with these compounds as compared to that with GSH conjugates (Table II) . DOX-stimulated ATP hydrolysis by DNP-SG ATPase purified from both erythrocytes and lung was linear with the amount of the purified enzyme used and with the incubation time for at least 60 min. The results of these experiments with the erythrocyte enzyme are presented in Fig.  2, A and B ; similar results were obtained with the lung enzyme. DOX-stimulated ATPase activity ofthe enzyme was abolished when the enzyme was preheated at 90'C for 5 min, a result consistent with the previously reported heat inactivation ofthis enzyme (20) .
The DOX-and doxorubicinone-stimulated ATP hydrolyzing activity ofthe purified erythrocyte enzyme was found to be immunoprecipitated (77 and 9 1%, respectively) by anti-DNP-SG ATPase antibodies in immunotitration experiments in which preimmune serum did not significantly affect the activity (Fig. 2 C) . In parallel experiments, the ATPase activity stimulated by the GSH conjugate (DNP-SG) used as a positive control was also immunoprecipitated to the extent of82% (Fig.   2 C) . Similar results were obtained with the purified enzyme from human lung (data not presented).
ATP hydrolysis by the human lung and erythrocyte DNP-SG ATPase by DOX and its metabolites was saturable at higher concentrations of these compounds. Linearity ofdouble reciprocal plots was observed for both human lung and erythrocyte enzymes with DOX and its metabolites as substrates (data not presented solutions to ensure that the osmolarity of the blank and reaction mixtures used for transport studies were identical. Using either NaCl or ADP in the controls to compensate for the osmolarity of ATP in the experimental reaction mixtures yielded similar results. Increased ATP-dependent uptake of DOX by the IOVs, as indicated by the association of [ 14C ] DOX radioactivity with the IOVs, was consistently seen in the presence of ATP as compared with the IOVs incubated in the presence of either ADP or NaCl. ATP-dependent uptake of DOX by the IOVs was linear with respect to the IOV protein concentration (Fig. 3 A) . These results were observed regardless of whether the Sephadex G-50 column filtration method of Penefsky (28) or the membrane filtration method developed by us was used to separate IOVs from free DOX in the reaction mixtures. However, the precision was significantly better with the nitrocellulose membrane filtration method, and thus, the data presented in this report are those obtained using the latter method. The ATP-dependent DOX uptake by the IOVs was rapid and approximately linear for the first 15 min, with an initial rate of -300 pmol/min per milligram of protein (Fig. 3 B) . Because outward diffusion of DOX (a freely membrane-permeable compound) should start as soon as a concentration gradient of DOX across the IOV membrane was generated, the stoichiometry between DOX uptake and ATP consumption was difficult to determine. The results presented in Fig. 3 C showed (Fig. 4) Figure 4 . Separation of IOVs and ROVs by wheat germ agglutinin affinity chromatography. Fractions of 0.5 ml each were collected after application of vesicle protein to a wheat germ agglutinin column with a constant flow rate of 6 ml / h. The arrow indicates the time at which elution with methyl a-Dmannopyranoside was begun. 962 Awasthi et al. The dependence of DOX uptake on ATP and on proper membrane sidedness indicated that the transport was mediated by an ATP-dependent pump. This was further verified by determining the activation energy ofthe transport, which is compatible with an enzymatic process, and by establishing the heat sensitivity of the process. The ATP-dependent DOX transport by IOVs was shown to be temperature dependent with rates of 2 1, 127, and 217 pmol/min per milligram protein at 4, 20, and 37°C, respectively, yielding an activation energy of -13 kcal/ mol. Inactivation of the transporter upon heating was demonstrated in two separate experiments. IOVs preheated at 45°C for 1 and 4 h transported DOX at 14.0 and 2.5 pmol/min per milligram protein, corresponding to 6 and 1% ofcontrol transport rate, respectively. In other experiments, IOVs were immersed in boiling water for 5 min, were cooled to room temperature, and were revesiculated by sonication. IOVs were then separated from the mixture of vesicles using a wheat germ agglutinin column which quantitatively retained ROVs. The transport of DOX in the heat-inactivated IOVs thus prepared was completely abolished (< 1% ofcontrol). The kinetic characterization of the transport mechanism for DOX during the present studies included the determination of the Km and V,,m values for its substrates, DOX and ATP (Fig. 6, A and B, respec- tively). The Km ofthe transporter for ATP was found to be 1.85 mM, which was in the same range as that reported for GSH conjugate transporter ( 16, 17, 21 ) . The Km of the transporter for DOX was found to be 1.7 MM, which was closely similar to the Km values (Table II) Inhibition ofDOX transport by substrates ofP-glycoprotein, GSH conjugates, and the antibodies against DNP-SG A TPase.
The overlap between the transport mechanism(s) for DOX and GSH conjugates was corroborated by the results ofexperiments showing that the ATP-dependent uptake of DOX by IOVs was competitively inhibited by DNP-SG (Fig. 6 A) and EA-SG (data not presented). The inhibitory effects of several classes of amphiphilic compounds including anthracyclines (mitoxantrone and daunorubicin), vinca alkaloid (vinblastine), calcium channel blocker (verapamil), bilirubin conjugate (bilirubin ditaurate), bile acid conjugates (taurolithocholate and taurodeoxycholate), and cyclosporin A on the transport of DOX were also examined. The inhibition constants and nature of inhibition for these compounds are presented in Table III. It is noteworthy that the known substrates of P-glycoprotein (vinblastine, daunomycin, vincristine, and mitoxantrone) and the known substrates of the DNP-SG ATPase (bilirubin ditaurate, DNP-SG, and EA-SG) were found to inhibit DOX transport in a competitive manner. In contrast, the amphiphilic bile salts which do not stimulate ATP hydrolysis by DNP-SG ATPase (20) were not inhibitory towards this transporter at concentrations up to 100 MM used in these studies. Interestingly, cyclosporin A, a compound which can reverse MDR in cells with or without P-glycoprotein overexpression, also inhibited this enzyme, albeit in a noncompetitive manner. Additional evidence for the shared transport mechanisms of DOX and GSH conjugates was provided by a significant inhibition of DOX transport in IOVs preincubated for 5 min with polyclonal antibodies against the human erythrocyte DNP-SG ATPase. Whereas -45% inhibition of the transport of DOX was observed in the IOVs coated with anti-DNP-SG ATPase antibodies, the preimmune serum showed no effect on the transport of DOX by the IOVs (Fig. 7) . Taken together, these results provided strong evidence that the ATP-dependent transport of GSH conjugates and DOX from human erythrocytes, lung, and possibly other tissues was mediated through shared mechanism(s) and that DNP-SG ATPase was a common component of this mechanism(s). Reconstitution studies. The purified DNP-SG ATPase protein used for reconstitution studies was essentially homogeneous as seen in SDS-PAGE and was the only protein recognized by anti-DNP-SG ATPase antibodies in Western blot analysis. This protein was not recognized by the C2 19 antibody (which recognizes P-glycoprotein) in Western blot analysis (data not presented). The results of DOX transport studies in IOVs reconstituted in the presence of increasing amounts of purified DNP-SG ATPase are presented in Fig. 8 . These results show a linear increase in DOX transport activity in IOVs reconstituted in the presence of increasing amounts of the purified DNP-SG ATPase. Activity was unaffected in IOVs reconstituted in the presence of increasing amounts of albumin.
Discussion
Although the DNP-SG ATPase was initially thought to be a transporter of GS-X conjugates ( 17) , structurally unrelated anionic compounds were later added to its list of substrates (20) . Present studies indicate a much broader role for the DNP-SG ATPase as a xenobiotic transporter because we now demonstrate that the weakly cationic compounds (doxorubicin, dihydrodoxorubicin, daunomycin, and vinblastine) and uncharged compounds (doxorubicinone, deoxydoxorubicinone, and dihydrodoxorubicinone) also stimulate ATP hydrolysis by DNP-SG ATPase, and that DOX, daunomycin, and vinblastine are transported across the erythrocyte membranes (which do not express mdr-1 gene product P-glycoprotein) through an ATP-dependent transport mechanism most likely mediated by DNP-SG ATPase. This exceptionally broad substrate specificity and its wide tissue distribution indicate that this versatile transport mechanism may function normally as an important efflux mechanism for both xenobiotics and endobiotics. Its ability to transport the lipophilic xenobiotics and the amphiphilic products of phase II detoxification puts it in a unique position. This is probably the only cellular defense sys- tem against toxic compounds characterized so far which may be involved in the protection against the toxic effects ofamphiphilic toxins as well as their phase I and II biotransformation products. The wide tissue distribution ( 19) and ability to transport DOX with a Km in the range of clinically achievable serum DOX concentrations is particularly interesting, suggesting that this transport mechanism may be important in protecting normal or malignant tissues from the toxic effects of DOX. The cytotoxicity of DOX is closely related to the degree of its intracellular accumulation (31 ) . Increased expression of P-glycoprotein, the best characterized mechanism for decreasing intracellular accumulation of DOX (3) (4) (5) (6) (7) (8) , has been shown to confer resistance to DOX (4, 8) . The GS-X transport mechanism appears to be similar to the P-glycoprotein and its related transporters not only because of its ability to transport DOX with a relatively low Km and its wide substrate specificity, but also because, similar to P-glycoprotein, it is present in the canalicular membrane ofhepatocytes (32) . Thus, in a manner analogous to the P-glycoprotein, the GS-X conjugate transport mechanism may also function to ameliorate the cytotoxicity of DOX, daunomycin, vinblastine, and possibly other structurally unrelated amphiphilic compounds. Several malignant cell lines displaying the MDR phenotype have been described which appear to actively extrude DOX without expressing the P-glycoprotein (8) (9) (10) (11) (12) (13) . It is also interesting to note that a recent study (7) comparing the kinetics of DOX efflux between intact malignant cells with or without P-glycoprotein overexpression has shown that although the initial rate of DOX efflux was greater in malignant cells overexpressing the P-glycoprotein, the subsequent steady state rate of DOX efflux was equal in cells with or without P-glycoprotein expression (7), which suggests that xenobiotic transport mechanisms distinct from the P-glycoprotein may also play a role in mediating energy-dependent efflux of DOX. The results of present studies provide strong support to this contention.
The cytotoxicity of DOX towards drug-resistant malignant cells expressing the P-glycoprotein can be enhanced by multiple, structurally unrelated, relatively noncytotoxic compounds, presumably through competitive inhibition of the Pglycoprotein-mediated effilux of DOX (3) (4) (5) . Because we have shown that GS-X conjugates are competitive inhibitors of DOX transport by this GS-X conjugate transporter, drugs such as ethacrynic acid which undergo extensive conjugation with GSH may also enhance the cytotoxicity of DOX. The coadministration of DOX with ethacrynic acid or other relatively nontoxic drugs which are metabolized to GS-X conjugates can thus be a novel approach for modulating the antineoplastic Antiserum (il effects of DOX. Since the relatively high expression ofglutathione S-transferases (GSTs) in many malignant tissues (33) may result in more rapid conversion of certain drugs (such as ethacrynic acid) to their GS-X conjugates, combinations of such drugs and DOX may be effective in selectively enhancing the cytotoxicity of DOX towards malignant cells overexpressing GSTs. This combination could be particularly useful for the treatment of drug-resistant malignancies overexpressing GSTix since ethacrynic acid is a preferred substrate of GST-7r, the overexpression of which has been shown to decrease the efficacy ofethacrynic acid in enhancing the cytotoxicity ofalkylating agents (34) . Further studies are required to explore these possibilities for enhancing the cytotoxic effects of DOX in MDR phenotypes.
